Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A3B5 can reduce skin pigmentation and slow melanoma growth.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Tofacitinib treatment is used for teenagers with alopecia areata.

New compounds were made that are promising for prostate cancer therapy.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The combination of encorafenib and binimetinib caused few skin issues.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

CTP-543 is generally safe for treating alopecia areata.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Upadacitinib effectively treats severe alopecia areata and is safe.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Isotretinoin is effective for severe acne but requires careful monitoring for side effects, especially in women who could become pregnant.

Oral bicalutamide is safe and effective for female hair loss.

Bicalutamide improves hair density in women safely.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Isotretinoin treatment in teens with acne can cause hormonal changes, leading to menstrual irregularity and increased hirsutism.